NordICC Colonoscopy Trial Results Should Be Read Alongside Sigmoidoscopy Evidence, Researchers Say

A correspondence in The Lancet argues that the NordICC trial's finding on colonoscopy screening should be interpreted in the context of four randomized trials covering more than 458,000 participants, which showed consistent reductions in colorectal cancer incidence and mortality with sigmoidoscopy.